Should I buy or sell Ergomed stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ERGO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERGO, but not buy additional shares or sell existing shares. View ERGO analyst ratings or view top-rated stocks .

What is Ergomed's stock price target for 2024?

3 brokers have issued 12-month price targets for Ergomed's stock. Their ERGO share price targets range from GBX 1,350 to GBX 1,450. On average, they predict the company's stock price to reach GBX 1,400 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price. View analysts price targets for ERGO or view top-rated stocks among Wall Street analysts .

How have ERGO shares performed in 2024?

Ergomed's stock was trading at GBX 1,346 at the beginning of 2024. Since then, ERGO shares have increased by 0.0% and is now trading at GBX 1,346. View the best growth stocks for 2024 here .

How were Ergomed's earnings last quarter?

Ergomed plc (LON:ERGO) issued its quarterly earnings results on Monday, September, 18th. The company reported $1.20 earnings per share for the quarter. The company earned $22.91 million during the quarter. Ergomed had a net margin of 9.87% and a trailing twelve-month return on equity of 18.08%.

What other stocks do shareholders of Ergomed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed investors own include Dicerna Pharmaceuticals (DRNA) , AbbVie (ABBV) , Axsome Therapeutics (AXSM) , FuelCell Energy (FCEL) , NIO (NIO) , Science Applications International (SAIC) , Northern Dynasty Minerals (NAK) , Tilray (TLRY) , Agilent Technologies (A) and American Express (AXP) .

How do I buy shares of Ergomed?

Shares of ERGO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:ERGO

Ergomed (ERGO) Share Price, News & Analysis

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Free ERGO Stock Alerts

GBX 1,346

0.00 (0.00%)

(As of 11/13/2023)

Compare

Today's Range: 1,346
▼
1,346
50-Day Range: 1,346
▼
1,346
52-Week Range: 895
▼
1,380

Volume: 280,999 shs
Average Volume: 346,578 shs
Market Capitalization: £701.00 million

P/E Ratio: 4,641.38
Dividend Yield: N/A
Price Target: GBX 1,400

Stock Analysis Analyst Forecasts Chart Headlines Insider Trades

Get Ergomed alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Ergomed Stock (LON:ERGO)

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.

ERGO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ERGO Stock News Headlines

February 6, 2024 | morningstar.com

Icon PLC IJF

January 14, 2024 | finanznachrichten.de

Green Mining Innovation: Neuer Chief Financing Officer

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 13, 2024 | finanznachrichten.de

Green Mining Innovation: New Chief Financing Officer

January 4, 2024 | msn.com

Permira Hires Maschmeyer From Vistria for Health-Care Investing

December 31, 2023 | msn.com

3 high-growth penny stocks to consider buying for 2024

November 14, 2023 | finance.yahoo.com

Ergomed strongly positioned for future growth in new partnership with Permira

October 19, 2023 | uk.finance.yahoo.com

Invesco Ltd: Form 8.3 - Ergomed PLC

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

October 10, 2023 | msn.com

Wakefield-based fds advises on sale of an Isle of Man pharmaceutical company to global firm Ergomed PLC

October 2, 2023 | uk.finance.yahoo.com

Man Group PLC : Form 8.3 - Ergomed plc

September 22, 2023 | marketwatch.com

Ergomed Expects to Meet Full-Year Views After Pretax Profit Edged Up

September 18, 2023 | finance.yahoo.com

Form 8.3 - Ergomed_PLC

September 12, 2023 | finanznachrichten.de

Samson Rock Capital LLP - Form 8.3 - Ergomed Plc

September 7, 2023 | finance.yahoo.com

Form 8.3 - ERGO LN

September 5, 2023 | msn.com

Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall

September 5, 2023 | msn.com

Life science founder net worth tops £120m after private equity swoop

September 4, 2023 | msn.com

Private equity swoops on UK pharma firm Ergomed in £703.1m deal

September 4, 2023 | thetimes.co.uk

UK’s Ergomed agrees £703m takeover by private equity firm Permira

September 4, 2023 | markets.businessinsider.com

Ergomed Share Price Surges Over 14% on Takeover Announcement

September 4, 2023 | ft.com

Ergomed/Permira: buyout group sees drug trial group as contract thriller

September 4, 2023 | uk.finance.yahoo.com

Form 8.3 - Octopus Investments - Ergomed plc

September 4, 2023 | msn.com

Bidco to acquire biopharmaceutical services company Ergomed

September 4, 2023 | msn.com

Signal: UK clinical trials provider Ergomed bought out in $888m deal

September 4, 2023 | yahoo.com

FTSE 100 Live: Asia shares lift, blue-chips seen higher

September 4, 2023 | msn.com

Private equity firm Permira to buy UK's Ergomed for 703 million pounds

September 4, 2023 | reuters.com

UK's Ergomed agrees for 703 million pound buyout deal with Permira

See More Headlines

Receive ERGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/18/2017
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:ERGO
CUSIP: N/A
CIK: N/A
Web: www.ergomedplc.com
Phone: +44-1483-503205
Fax: N/A
Employees: 1,400
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 1,400
High Stock Price Target: GBX 1,450
Low Stock Price Target: GBX 1,350
Potential Upside/Downside: +4.0%
Consensus Rating: Hold
Rating Score (0-4): 2.33
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX 0.29
Trailing P/E Ratio: 4,641.38
Forward P/E Ratio: 26.11
P/E Growth: N/A
Net Income: £15 million
Net Margins: 9.87%
Pretax Margin: N/A
Return on Equity: 18.08%
Return on Assets: 10.16%

Debt

Debt-to-Equity Ratio: 3.32
Current Ratio: 1.79
Quick Ratio: 1.22

Sales & Book Value

Annual Sales: £152.09 million
Price / Sales: 4.61
Cash Flow: GBX 24.62 per share
Price / Cash Flow: 54.67
Book Value: GBX 179 per share
Price / Book: 7.52

Miscellaneous

Outstanding Shares: 52,080,000
Free Float: N/A
Market Cap: £701.00 million
Optionable: Not Optionable
Beta: 0.79

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Dr. Miroslav Reljanovic (Age 64)
Founder & Executive Chairman
Comp: $964.3k
Mr. Michael William Spiteri (Age 62)
Chief Transformation & Technology Officer
Comp: $52.77k
Jonathan Andrew Curtain (Age 47)
CFO & Executive Director
Dr. Michael Forstner
Head of Risk Management & Pharmacoepidemiology
Ms. Sally Amanuel
President of PrimeVigilance
Dr. Gordana Tonkovic
President of Clinical Research
Ms. Ronel Steyn
Senior Vice President of Global Development
Keith Byrne
Senior Vice-President of Capital Markets & Strategy
Joanne Bletcher
Company Secretary

Key Competitors

View All Competitors

ERGO Stock Analysis - Frequently Asked Questions

Should I buy or sell Ergomed stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ERGO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERGO, but not buy additional shares or sell existing shares.
View ERGO analyst ratings or view top-rated stocks.
What is Ergomed's stock price target for 2024?: 3 brokers have issued 12-month price targets for Ergomed's stock. Their ERGO share price targets range from GBX 1,350 to GBX 1,450. On average, they predict the company's stock price to reach GBX 1,400 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts price targets for ERGO or view top-rated stocks among Wall Street analysts.
How have ERGO shares performed in 2024?: Ergomed's stock was trading at GBX 1,346 at the beginning of 2024. Since then, ERGO shares have increased by 0.0% and is now trading at GBX 1,346.
View the best growth stocks for 2024 here.
How were Ergomed's earnings last quarter?: Ergomed plc (LON:ERGO) issued its quarterly earnings results on Monday, September, 18th. The company reported $1.20 earnings per share for the quarter. The company earned $22.91 million during the quarter. Ergomed had a net margin of 9.87% and a trailing twelve-month return on equity of 18.08%.

What other stocks do shareholders of Ergomed own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed investors own include Dicerna Pharmaceuticals (DRNA), AbbVie (ABBV), Axsome Therapeutics (AXSM), FuelCell Energy (FCEL), NIO (NIO), Science Applications International (SAIC), Northern Dynasty Minerals (NAK), Tilray (TLRY), Agilent Technologies (A) and American Express (AXP).
How do I buy shares of Ergomed?: Shares of ERGO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ERGO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ergomed (ERGO) Share Price, News & Analysis

About Ergomed Stock (LON:ERGO)

ERGO Stock Price History

ERGO Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ERGO Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info